Kun Cheng

Kun Cheng


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2021 in Frontiers in Surgery
Verified
Journal Article
Open access
XSXianhao Shao
Xianhao Shao
JLJianmin Li
Jianmin Li
AZAilin Zhang
Ailin Zhang
YYYuan Yao
Yuan Yao
FSFeifei Sun
Feifei Sun
KCKun Cheng
Kun Cheng
Objective: This research aims to refresh the limited understanding about the canal and vascular structures within the epiphysis and metaphysis of the tibia and femur and their oncological significance.Methods: This study was started with characterization of a novel structure using radiographs and anatomic dissections, followed by a descriptive clinical study with 55 participants to investigate the effects of tumors on this novel discovery and a retrospective cohort study with 82 participants to investigate whether the structure would be a risk factor for tumor recurrence after the curettage of giant cell tumor of bone.Results: A new anatomical knee structure, the Lijianmin-Chengkun (LC) complex, was discovered in healthy adults, and its clinical implications were examined in this study. This new-found anatomical structure is composed of an epiphyseal and metaphyseal canal which surrounds a blood vessel, foramen, and foramen-covered synovium. All LC complexes showed similar radiographical, anatomical, and histological characteristics and were located within specific tibial and femoral intercondylar regions. These LC complexes seem to facilitate tumor residue and extension and may be a risk factor for tumor recurrence after curettage of femoral and tibial giant cell tumors (P = 0.031).Conclusion: The LC complexes are related to local tumor recurrence and bidirectional tumor dissemination between intraosseous and intraarticular regions. These findings have opened up a new perspective and may provide new targets for intervention in malignant and aggressive tumors around the knee joint.

24 February 2022 in Orthopaedic Surgery
Verified
Journal Article
Open access
PDF file
XSXianhao Shao
Xianhao Shao
JLJian‐Min Li
Jian‐Min Li
AZAi‐Lin Zhang
Ai‐Lin Zhang
YYYuan Yao
Yuan Yao
FSFei‐Fei Sun
Fei‐Fei Sun
KCKun Cheng
Kun Cheng
Objective: To explore whether there exist undiscovered transphyseal vasculature‐canal compound structures in immature femurs and tibias, and reveal their potential oncological impact.Methods: This investigation was divided into a morphological study and a clinical study. In the morphological part, a new‐identified anatomic structure was investigated by using radiographical, anatomical, and histological methodologies. Twenty‐eight 1‐mm‐slice thickness magnetic resonance images of pediatric knees were generated and 10 pediatric knees were dissected to verify the existence and universality, observe the radiographic and anatomic characteristics, and determined the located region of this structure. Hematoxylin–eosin staining, immunofluorescence, and angiography procedures were performed to illustrate its histological feature, molecular identification, and vascular origination, respectively. In the clinical part, 38 pediatric osteosarcoma patients were enrolled from January 2014 to December 2020. A descriptive clinical study including 13 typical participants was conducted to investigate the oncological significance of this new‐identified structure. Meanwhile, the discrepancy in transphyseal osteosarcoma extension between different physeal regions was evaluated in a cross‐sectional study.Results: In the morphological study, we discovered a new‐found vasculature‐canal compound structure, intercondylar transphyseal complex (ITC), which originated from the middle genicular vessels, traversed the whole epiphysis, and breached the intact open physis in the immature proximal tibia or distal femur. The components of ITC included the juxta‐articular, epiphyseal, and transphyseal segments of vessels, the canals that traverse the entire epiphysis and physis and enclosed the vessels, vascular foramina on articular facet and foramina‐covered synovium. Depending on the location, ITCs can be divided into three types: femoral ITC, anterior tibial ITC, and posterior tibial ITC. Clinically, the ITC may facilitate intercondylar transphyseal sarcomatous dissemination without damaging the adjacent physeal cartilage. Compared to bilateral condylar physes, more osteosarcomas transgressed the open growth plates through intercondylar regions in which ITC was located (P = 0.022).Conclusion: As the “gap” on intact open physis, ITC, which is a new‐identified compound structure in intercondylar regions of immature femur or tibia, may promote intercondylar transphyseal tumor extension. Moreover, the identification and characterization of ITC subvert some traditional comprehensions about physis and may provide novel perspectives for pediatric osteosarcomas.

11 August 2025 in Orthopaedic Surgery
Verified
Journal Article
Open access
MDMengmeng Dou
Mengmeng Dou
JYJinfeng Yang
Jinfeng Yang
JLJiaoran Li
Jiaoran Li
JLJianmin Li
Jianmin Li
ZLZhenzhong Li
Zhenzhong Li
KCKun Cheng
Kun Cheng
Objective: The objective of this study is to achieve distinct visualization of juxta‐articular intraosseous microvessels, a novel nanoimaging methodology in which superparamagnetic iron oxide nanoparticles and meglumine diatrizoate (MD) are used cooperatively was implemented.Methods: A newly created composite of MD and Fe3O4 nanoparticles (MD‐Fe3O4 NPs) was prepared as a contrast agent to achieve efficacious imaging of the juxta‐articular intraosseous vasculature‐canal complex (JIVCC). Scanning electron microscopy (SEM) and energy dispersive spectrum (EDS) were employed to observe the structural characteristics and binding stability of the MD‐Fe3O4 NPs. In 20 rabbits that received an injection of MD‐Fe3O4 NPs, 1‐mm‐thick computed tomography (CT) scanning was performed for radiographic assessment. Hematoxylin–eosin‐ and potassium ferrocyanide‐stained sections from 10 sacrificed rabbits were used to observe the histological characteristics of JIVCC with MD‐Fe3O4 NPs, and the remaining 10 rabbits were utilized for a systemic safety evaluation. After a healthy volunteer received an MD‐Fe3O4 NP injection, we also performed CT scanning and related safety evaluations.Results: When the MD nanoparticles and amino‐Fe3O4 nanoparticles were mixed together, they aggregated into a stable compound structure according to microscopic observations and SEM–EDS verification. In 20 rabbits receiving MD‐Fe3O4 injections, 1‐mm slice CT imaging demonstrated significantly enhanced visualization of the JIVCCs in magnet‐placed knees compared to contralateral limbs (tibial JIVCC: p < 0.001; femoral JIVCC: p < 0.001), confirming MD‐Fe3O4 NPs as the efficacious magnetic contrast enhancer. The histological characteristics of MD‐Fe3O4 NPs in JIVCC were revealed. The levels of serum iron before and 4 and 72 h after MD‐Fe3O4 NP injection were 23.9 ± 2.13 μmol/L, 26.2 ± 2.30 μmol/L, and 24.9 ± 2.33 μmol/L, respectively, indicating that there was no significant difference in safety (p = 0.092). After a volunteer received MD‐Fe3O4 NPs via intravenous administration, the JIVCC was clearly visualized, laboratory tests of serum iron levels were normal, and no injection‐related complications occurred.Conclusions: A novel compound nanoparticle, which achieved satisfactory overall outcomes, was implemented as an appropriate alternative for the discernible visualization of juxta‐articular intraosseous microvessels. The nanotechnology utilized in this study may augment the clinical imaging methodology for the osseous vascular system.